Salmon, Gary
90  results:
Search for persons X
?
1

Discovery of a class of highly potent Janus Kinase 1/2 (JAK..:

Zak, Mark ; Hanan, Emily J. ; Lupardus, Patrick...
Bioorganic & Medicinal Chemistry Letters.  29 (2019)  12 - p. 1522-1531 , 2019
 
?
2

Discovery of oxa-sultams as RORc inverse agonists showing r..:

René, Olivier ; Fauber, Benjamin P. ; Barnard, Adrian...
Bioorganic & Medicinal Chemistry Letters.  26 (2016)  18 - p. 4455-4461 , 2016
 
?
3

Discovery of imidazo[1,5-a]pyridines and -pyrimidines as po..:

Fauber, Benjamin P. ; Gobbi, Alberto ; Robarge, Kirk...
Bioorganic & Medicinal Chemistry Letters.  25 (2015)  15 - p. 2907-2912 , 2015
 
?
4

Small, non-peptide C5a receptor antagonists: Part 2:

Blagg, Julian ; Mowbray, Charles ; Pryde, David...
Bioorganic & Medicinal Chemistry Letters.  18 (2008)  20 - p. 5605-5608 , 2008
 
?
5

Small, non-peptide C5a receptor antagonists: Part 1:

Blagg, Julian ; Mowbray, Charles ; Pryde, David C....
Bioorganic & Medicinal Chemistry Letters.  18 (2008)  20 - p. 5601-5604 , 2008
 
?
10

Early Experience With a Novel Miniaturized Spinal Cord Stim..:

Salmon, John ; Bates, Dan ; Du Toit, Neels...
Neuromodulation: Technology at the Neural Interface.  26 (2023)  1 - p. 172-181 , 2023
 
?
11

ID:16028 Long-Term Results of a Prospective, Multi-Center T..:

Verrills, Paul ; Salmon, John ; Bates, Dan...
Neuromodulation: Technology at the Neural Interface.  25 (2022)  4 - p. S37 , 2022
 
?
12

ID:16026 Novel SCS Waveform Produces Significant Improvemen..:

Bates, Dan ; Verrills, Paul ; Salmon, John...
Neuromodulation: Technology at the Neural Interface.  25 (2022)  4 - p. S37 , 2022
 
?
13

ID:16601 Long-Term Results of a Novel, Externally-Powered, ..:

Verrills, Paul ; Salmon, John ; Bates, Dan...
Neuromodulation: Technology at the Neural Interface.  25 (2022)  5 - p. S43-S44 , 2022
 
1-15